Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-31

Clinical Trial Update: Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia. [Phase 3]

View source ↗

Summary

Phase 3 trial on albumin administration in hypoalbuminemic hospitalized patients with community-acquired pneumonia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Jordi Carratala | Conditions: Community-acquired Pneumonia, Hypoalbuminemia | Phase 3 | Status: TERMINATED